BackIronwood Pharmaceuticals Overview

Ironwood Pharmaceuticals Selling, General & Admin

Selling, General & Admin expenses for IRWD.

Quarterly SG&A Expenses

$12.03M
↓ 50.4% YoY

As of Mar 31, 2026

Annual SG&A Expenses (TTM)

$70.03M
↓ 46.51% YoY

Trailing 12 months ending Mar 31, 2026

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin